QIMA Life Sciences (previously Bioalternatives and Synelvia) is a Contract Research Organization (CRO) established in 1996 and specializing in cellular and molecular pharmacology.

We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays.

QIMA Life Sciences contributes to the development of in vitro methods as an alternative to animal experimentation, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations.

Beyond this activity of product evaluation and development and thanks to our offer of customized competitive services based on collaborative innovation, QIMA Life Sciences can assist the health industry with its new strategic choices.

Our assays are performed on our two French sites, in Gençay (Vienne) and Labège (Haute-Garonne).

With 60 experts and two 1000 square meter laboratories, our firm helps the marketing and R&D departments of big European and American cosmetic and pharmaceutical groups to innovate in the field of project conceptualization and to substantiate and support their product claims.